Rhythm Pharmaceuticals Stock Forward View - Simple Regression
| RYTM Stock | USD 87.45 -2.86 -3.17% |
Rhythm Pharmaceuticals's Simple Regression forecast reference data is generated from the equity's historical trading prices. This page presents the model output and associated accuracy measures as reference information.
The Simple Regression forecasted value of Rhythm Pharmaceuticals on the next trading day is expected to be 89.18 with a mean absolute deviation of 2.91 and the sum of the absolute errors of 180.43.In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as Rhythm Pharmaceuticals historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data. The Simple Regression projections for Rhythm Pharmaceuticals are reference data based on historical daily prices and are provided as informational context. Simple Regression Price Forecast For the 22nd of March
Given 90 days horizon, the Simple Regression forecasted value of Rhythm Pharmaceuticals on the next trading day is expected to be 89.18 with a mean absolute deviation of 2.91 , mean absolute percentage error of 13.84 , and the sum of the absolute errors of 180.43 .Please note that although there have been many attempts to predict Rhythm Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Rhythm Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Rhythm Pharmaceuticals | Rhythm Pharmaceuticals Price Prediction | Research Analysis |
Forecasted Value
The next-day forecast for Rhythm Pharmaceuticals focuses on identifying predictive downside and upside bands that can frame a realistic trading range. At the moment, the model places downside around 86.15 and upside around 92.22 for the forecasting period.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Rhythm Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Rhythm Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 122.5762 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 2.9102 |
| MAPE | Mean absolute percentage error | 0.0289 |
| SAE | Sum of the absolute errors | 180.4303 |
Other Forecasting Options for Rhythm Pharmaceuticals
The price trajectory of Rhythm is the primary concern for any investor assessing it as an opportunity. Rhythm Stock price charts are filled with noise that can easily mislead uninformed investment decisions.View Rhythm Pharmaceuticals' Related Equities
| Risk & Return | Correlation |
Rhythm Pharmaceuticals Market Strength Events
Understanding the market strength of Rhythm Pharmaceuticals stock enables investors to assess the security's momentum and responsiveness to broader market forces. These indicators are essential tools for timing trades in Rhythm Pharmaceuticals with greater precision.
| Accumulation Distribution | 412276.0 | |||
| Daily Balance Of Power | -0.21 | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 93.27 | |||
| Day Typical Price | 91.33 | |||
| Price Action Indicator | -7.25 | |||
| Period Momentum Indicator | -2.86 |
Rhythm Pharmaceuticals Risk Indicators
Reviewing Rhythm Pharmaceuticals' basic risk indicators is essential for investors who want to forecast its price and manage their investment risk effectively. This analysis helps identify the amount of risk involved in holding Rhythm Pharmaceuticals' and informs decisions about hedging and position.
| Mean Deviation | 2.35 | |||
| Standard Deviation | 2.92 | |||
| Variance | 8.54 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Rhythm Pharmaceuticals
Coverage intensity for Rhythm Pharmaceuticals matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Rhythm Pharmaceuticals Short Properties
Short sentiment tied to Rhythm Pharmaceuticals matters because heavier bearish pressure can change how quickly future price expectations become unstable. This is most valuable when investors want to know whether bearish pressure is starting to shape the market's reaction function.
| Common Stock Shares Outstanding | 65 M | |
| Cash And Short Term Investments | 388.9 M |